Connection

MOSTAFA GABER to Cell Line, Tumor

This is a "connection" page, showing publications MOSTAFA GABER has written about Cell Line, Tumor.
Connection Strength

0.119
  1. In?Vitro and In?Vivo Characterization of a Preclinical Irradiation-Adapted Model for Ewing Sarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):118-127.
    View in: PubMed
    Score: 0.023
  2. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
    View in: PubMed
    Score: 0.020
  3. Vascular-targeted photothermal therapy of an orthotopic murine glioma model. Nanomedicine (Lond). 2012 Aug; 7(8):1133-48.
    View in: PubMed
    Score: 0.015
  4. IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation. Mol Cancer Ther. 2010 Mar; 9(3):761-71.
    View in: PubMed
    Score: 0.013
  5. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials. 2010 May; 31(14):4157-66.
    View in: PubMed
    Score: 0.013
  6. Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells. J Biomed Mater Res B Appl Biomater. 2009 Jul; 90(1):145-55.
    View in: PubMed
    Score: 0.012
  7. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials. 2009 Sep; 30(27):4743-51.
    View in: PubMed
    Score: 0.012
  8. Continuous delivery of IFN-beta promotes sustained maturation of intratumoral vasculature. Mol Cancer Res. 2007 Jun; 5(6):531-42.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.